© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
May 27, 2021
Incidence rates of early-onset colorectal cancer in the United States have increased from 8.6 to 13.1 per 100,000 between 1992 and 2013, with most of this increase attributable to early-onset cancers of the rectum.
May 20, 2021
The percentage dropped to only about 25% among people at a low genetic risk for the disease.
May 18, 2021
The incidence of colorectal cancer in adults between the ages of 40 and 49 years has increased by nearly 15% since 2000.
May 13, 2021
The implementation of multi-gene panel testing may be a necessary part of the standard of care for all colorectal cancer patients.
May 11, 2021
In June 2020, the FDA granted a fast track designation to fruquintinib for patients with mCRC previously treated with other therapies.
April 30, 2021
Individuals with an average risk of colorectal cancer said they would prefer a stool-based screening test for colorectal cancer over colonoscopy.
March 31, 2021
The study also analyzed the relationship between ultra-processed food and drink products with 2 other cancer types.
March 25, 2021
A new study published in The American Journal of Clinical Nutrition found that for colorectal cancer survivors, maintaining a stable body weight may hide a loss of muscle and the development of fatty deposits in their muscles, which resulted in a 40% higher risk of premature death.
February 04, 2021
The findings suggest pre-diagnosis aspirin use might help reduce CRC mortality in the overall population by limiting metastatic spread of colorectal tumors before diagnosis.
January 29, 2021
If approved, the biosimilar will be indicated for use in metastatic colorectal cancer, nonsquamous non–small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, and metastatic cervical cancer.